Nuveen Asset Management, LLC Dexcom Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 8,086,482 shares of DXCM stock, worth $643 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

8,086,482

Previous 6,440,337 25.56%

Holding current value

$643 Million

Previous $730 Million 25.78%

% of portfolio

0.16%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $105 Million - $191 Million	1,646,145 Added 25.56%	8,086,482 $542 Million
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $90.1 Million - $115 Million	-817,204 Reduced 11.26%	6,440,337 $730 Million
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $26.8 Million - $32.9 Million	-234,751 Reduced 3.13%	7,257,541 $1.01 Billion
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $19.5 Million - $32 Million	-257,773 Reduced 3.33%	7,492,292 $930 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $15.8 Million - $25.4 Million	-184,085 Reduced 2.32%	7,750,065 $723 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $8.57 Million - $9.98 Million	76,228 Added 0.97%	7,934,150 $1.02 Billion
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $14.8 Million - $17.4 Million	141,952 Added 1.84%	7,857,922 $913 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $68.4 Million - $98.7 Million	-804,687 Reduced 9.44%	7,715,970 $874 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $17.6 Million - $21.7 Million	230,774 Added 2.78%	8,520,657 $686 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $414 Million - $810 Million	6,091,559 Added 277.1%	8,289,883 $618 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $14 Million - $19.4 Million	148,757 Added 7.26%	2,198,324 $1.01 Billion
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $5.94 Million - $7.44 Million	-45,709 Reduced 2.18%	2,049,567 $1.1 Billion
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $28.3 Million - $37.9 Million	264,852 Added 14.47%	2,095,276 $1.15 Billion
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $43.9 Million - $58.5 Million	542,070 Added 42.07%	1,830,424 $782 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $16.9 Million - $20.9 Million	199,383 Added 18.31%	1,288,354 $463 Million
Q4 2020 May 17, 2021	SELL	$78.0 - $104.5 $75,582 - $101,260	-969 Reduced 0.09%	1,088,971 $403 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $22.4 Million - $30 Million	286,652 Added 35.68%	1,089,940 $403 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $6.18 Million - $7.31 Million	64,751 Added 8.77%	803,288 $331 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $15.5 Million - $26 Million	-246,599 Reduced 25.03%	738,537 $299 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $425,856 - $673,938	-8,911 Reduced 0.9%	985,136 $66.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $1.75 Million - $2.74 Million	-47,755 Reduced 4.58%	994,047 $217 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $2.34 Million - $2.89 Million	-65,933 Reduced 5.95%	1,041,802 $155 Million
Q2 2019 Aug 15, 2019	BUY	$27.84 - $38.92 $29.2 Million - $40.8 Million	1,048,855 Added 1781.34%	1,107,735 $166 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $506,270 - $688,614	18,036 Added 44.16%	58,880 $7.01 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $170,684 - $236,327	-6,324 Reduced 13.41%	40,844 $4.89 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $1.1 Million - $1.73 Million	47,168 New	47,168 $6.75 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $1.39 Million - $1.93 Million	-125,283 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.42 Million - $2.38 Million	125,283	125,283 $6.13 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.7B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Dexcom Inc Transaction History